Skip to main content

Research Repository

Advanced Search

Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals

Borg, M A; Zerafa, R; Morrison, Donald; Cuschieri, P

Authors

M A Borg

R Zerafa

P Cuschieri



Abstract

The incidence of hetero-intermediate glycopeptide
susceptibility among Staphylococcus aureus
isolates in Malta, a country with a high incidence
of methicillin resistance, was studied by screening
454 non-repetitive S. aureus isolates on teicoplanin-
supplemented agar plates, followed by Etests
and genotypic studies. All strains were susceptible
to vancomycin, but four (0.88%) exhibited
teicoplanin MICs of > 12 mg⁄ L. High methicillinresistant
S. aureus endemicity was not an accurate
predictor of the emergence of non-susceptibility
to glycopeptides.

Citation

Borg, M. A., Zerafa, R., Morrison, D., & Cuschieri, P. (2005). Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals. Clinical Microbiology and Infection, 11(5), 405-407. https://doi.org/10.1111/j.1469-0691.2005.01110.x

Journal Article Type Article
Publication Date 2005-05
Deposit Date Jun 12, 2015
Print ISSN 1198-743X
Electronic ISSN 1469-0691
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 11
Issue 5
Pages 405-407
DOI https://doi.org/10.1111/j.1469-0691.2005.01110.x
Keywords h-GISA; Malta; resistance, Staphylococcus aureus; teicoplanin; vancomycin;
Public URL http://researchrepository.napier.ac.uk/id/eprint/8678
Publisher URL http://dx.doi.org/10.1111/j.1469-0691.2005.01110.x